Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics-Reference-Cited by-同舟云学术

Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics

Published:2015-01-20 Issue:3 Volume:97 Page:298-306
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Olagunju A¹²,Bolaji O²,Amara A³,Else L³,Okafor O⁴,Adejuyigbe E⁵,Oyigboja J⁶,Back D¹,Khoo S¹,Owen A¹

Affiliation:

1. Department of Molecular and Clinical Pharmacology; University of Liverpool; Liverpool UK

2. Faculty of Pharmacy; Obafemi Awolowo University; Ile-Ife Nigeria

3. Liverpool Bioanalytical Facility; Department of Molecular and Clinical Pharmacology; University of Liverpool; Liverpool UK

4. Bishop Murray Medical Centre; Makurdi Nigeria

5. Faculty of Clinical Sciences, Obafemi Awolowo University; Ile-Ife Nigeria

6. Clinical Services, Catholic Caritas Foundation of Nigeria; Abuja Nigeria

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.43/fullpdf

Reference48 articles.

1. World Health Organization http://www.who.int/entity/hiv/pub/mtct/strategic_vision.pdf

2. World Health Organization http://www.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf

3. Impact of an innovative approach to prevent mother-to-child transmission of HIV - Malawi, July 2011-September 2012;Centers for Disease Control and Prevention;MMWR Morb. Mortal. Wkly. Rep,2013

4. World Health Organization http://whqlibdoc.who.int/hq/2012/WHO_HIV_2012.6_eng.pdf

5. World Health Organization http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf?ua=1

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prenatal efavirenz exposure is independently associated with maternal, but not fetal CYP2B6 genotype;Pharmacogenetics and Genomics;2024-06-24

2. Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum;Clinical Pharmacology & Therapeutics;2024-06-10

3. Pharmacogenetics of efavirenz exposure in cervicovaginal fluid during pregnancy and postpartum;2023-10-15

4. Mechanistic Modeling of the Drug‐Drug Interaction Between Efavirenz and Dolutegravir: Is This Interaction Clinically Relevant When Switching From Efavirenz to Dolutegravir During Pregnancy?;The Journal of Clinical Pharmacology;2023-06

5. Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans;International Journal of Hypertension;2023-05-30